Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
57 hedge funds and large institutions have $87.8M invested in Genocea Biosciences, Inc. in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 20 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less funds holding
Funds holding: 70 → 57 (-13)
26% less capital invested
Capital invested by funds: $118M → $87.8M (-$30.5M)
65% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$6.45M |
| 2 |
DM
Deerfield Management
New York
|
+$2M |
| 3 |
AIC
AWM Investment Company
New York
|
+$1.33M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$973K |
| 5 |
JP Morgan Chase
New York
|
+$814K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
Tourbillon Capital Partners
New York
|
-$4.79M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.41M |
| 3 |
Millennium Management
New York
|
-$3.06M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.51M |
| 5 |
BC
Broadfin Capital
New York
|
-$1.19M |
GNCA Hedge Fund Activity: Q4 2015 in Review
57 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q4 2015, worth a combined $87.8M — down 26% from $118M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of GNCA and 7 opened new positions — a net loss of 13 holders — while 15 trimmed existing stakes and 25 added.
The largest buyer was Franklin Resources, adding an estimated $6.45M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $4.79M sold.
- 57 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q4 2015, down from 70 in Q3 2015.
- Funds reported $87.8M of Genocea Biosciences, Inc. stock for Q4 2015, down 26% quarter-over-quarter.
- 7 funds opened new Genocea Biosciences, Inc. positions in Q4 2015 and 20 closed out, a net change of -13 holders.
- The largest Genocea Biosciences, Inc. buyer in Q4 2015 was Franklin Resources, an estimated $6.45M added.
- The largest Genocea Biosciences, Inc. seller in Q4 2015 was Tourbillon Capital Partners, an estimated $4.79M sold.
Based on aggregated 13F filings for Q4 2015.